Clinical Trial Update: A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial evaluating the safety and efficacy of taliglucerase alfa in subjects with Gaucher disease, Type 3, has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Taliglucerase alfa (taliglucerase alfa)

Snippet

Sponsor: Ari Zimran | Conditions: Gaucher Disease, Type 3 | Phase 4 | Status: COMPLETED | Results posted: 2024-12-17